---
schema_version: "secwatch.filing_event.v1"
accession: "0001274737-21-000106"
form_type: "8-K"
ticker: "XGN"
cik: "0001274737"
company_name: "EXAGEN INC."
filed_at: "2021-10-25T23:59:59+00:00"
generated_at: "2026-06-28T18:21:55.132838+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Exagen refinances $27.2M term loan with Innovatus; maturity extended to Nov 2026

## Summary
- $27.2M term loan at 8.0% interest (2% paid in-kind) from Innovatus.
- Interest-only period extended through December 2024; maturity extended to November 19, 2026.
- Financial covenant revised to revenue-based test starting Q4 2022, with cure options via equity or sub debt.
- Effective November 1, 2021; press release issued October 25, 2021.

## SEC filing metadata
- accession: 0001274737-21-000106
- form_type: 8-K
- ticker: XGN
- cik: 0001274737
- company_name: EXAGEN INC.
- filed_at: 2021-10-25T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000106/0001274737-21-000106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000106/exdx-20211021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001274737-21-000106
- JSON: https://secwatch.observer/filing/0001274737-21-000106.json
- Plain text: https://secwatch.observer/filing/0001274737-21-000106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.